Professional Documents
Culture Documents
Jagan
Associate Professor of Pharmacology
HOD – Para clinical Department
Texila American University
Learning Objectives
• Classify Muscarinic Receptor Antagonist.
• List the major clinical indications and Side effects of
muscarinic receptor antagonist.
• Contraindications for the use of muscarinic receptor
antagonists.
• List one antimuscarinic agent promoted for each of the
following uses: to produce mydriasis and cycloplegia; to
treat parkinsonism; asthma; bladder spasm and OP
poisoning.
• List the signs, symptom and treatment of atropine
overdose.
Parasympatholytics
Anticholinergic drugs
Competitive antagonists.
Classification:
1.Natural Alkaloids
2.Semi -synthetic Derivatives
3.Synthetic Compounds
1. Natural Alkaloids:
•Atropine, Hyoscine (Scopolamine)
2. Semisynthetic Derivatives:
•Homatropine,
•Atropine metho nitrate,
•Hyoscine butyl bromide
•Ipratropium bromide
•Tiotropium bromide.
3.Synthetic Compounds:
a) Mydriatic – Cyclopentolate,Tropicamide
b) Antisecretory – Antispasmodic
i) Quaternary Compounds
Propantheline,Oxyphenonium,Clidinium
Pipenzolate , Glyclopyrrolate
ii) Tertiary Amines
Dicyclomine,Oxybutynin,Flavoxate,
Pirenzepine, Telenzepine
c) Antiparkinsonism Drugs
Benztropine
Trihexyphenidyl or Benzhexol
Procyclidine
Biperiden
1. Natural Alkaloids:
1) Atropine
Atropa belladonna
(Deadly night shade)
Datura stramonium
2) Hyoscine
(Scopolamine)
Hyoscyamus niger
Pharmacokinetics
1. Absorption:
• Well absorbed orally & cross the
conjunctival membrane
• Scopalamine Transdermal.
2. Distribution:
• Widely distributed
• Scopalamine CNS
3. Metabolism:
• 50% Atropine & 80% Scopalamine
Conjugation (Phase-II).
• Black rabbits atropine esterase.
4. Excretion:
• 50% unchanged in urine
• Plasma t1/2 : 3 hr
• Effect on eye persists for 72 hrs
Mechanism of Action
• Competitive blockade of Muscarinic
receptors (M1- M3).
• IP3- DAG M1 – M3.
• CAMP M2
Pharmacological actions
1.CNS :
High dose atropine CNS stimulation
Therapeutic doses Scopalamine
drowsiness, Amnesia
a. Depression of vestibular
excitation - motion sickness
b. Blocks cholinergic activity in
basal ganglia: tremor and
rigidity of parkinsonism
2. Cardiovascular System
Heart Rate:
• M2 receptor blockade Tachycardia.
• Shortens refractory period and facilitates AV
conduction.
BP:
• BP : Tachycardia and Vasomotor
A. OP poisoning
B. Motion sickness
C. Parkinson’s disease
D. Postoperative bladder spasm
8
A 38-year-old farmer is brought to the ER by his wife with symptoms
of sudden difficulty breathing, sweatiness, and anxiety. He was
spraying insecticide when this happened. It has been 25 minutes
since the symptoms started. The patient is emergently intubated and
given atropine and another medication that acts to reactivate
acetylcholinesterase. What medication is it?
A) Physostigmine
B) Propranolol
C) Pralidoxime
D) Phenylephrine
E) Pancuronium
9
A 78-year-old man with Parkinson disease experiences
worsening of his symptoms. He is already taking levodopa.
Since the disease is characterized by degeneration of
dopaminergic neurons, leading to the lack of inhibition of
cholinergic neurons, the addition of which medication is
likely to help alleviate the patient’s symptoms?
A) Benztropine
B) Reserpine
C) Doxazocin
D) Timolol
E) Tubocurarine
10
Receptor actions of acetylcholine are mimicked by nicotine at
which one of the following sites?
A) Adrenal medullary chromaffin cells
B) Urinary bladder smooth muscle cells
C) Iris circular (constrictor) muscle
D) Heart sinoatrial pacemaker cells
11
Which one of the following agents, when applied topically to
the eye, would cause both mydriasis and cycloplegia?
A) Phenylephrine
B) Carbachol
C) Prazosin
D) Atropine